PMID- 27975336 OWN - NLM STAT- MEDLINE DCOM- 20170830 LR - 20170921 IS - 1438-8812 (Electronic) IS - 0013-726X (Linking) VI - 49 IP - 1 DP - 2017 Jan TI - Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study. PG - 27-34 LID - 10.1055/s-0042-119402 [doi] AB - Background and aims In multiple endocrine neoplasia type 1 (MEN1), endoscopic ultrasound (EUS) is used for identification and follow-up of pancreatic neuroendocrine tumors (PNETs). The role of EUS in surveillance of small ( < 20 mm) PNETs is unclear, mostly because the natural course of these lesions is largely unknown. We aimed to determine annual growth and incidence rate of small PNETs in patients with MEN1 using EUS-based surveillance. Patients and methods Linear array EUS procedures in patients with MEN1 between 2002 and 2015 were identified. Number, size, and location of PNETs were recorded. Annual growth of PNETs < 20 mm identified at the initial EUS ("prevalent" PNETs) and during follow-up ("incident" PNETs) was calculated using mixed model linear regression analysis. Results A total of 54 patients were identified and 38 patients were included. In all, 226 PNETs were identified (median size 5.0 mm, interquartile range 3.7 - 7.5) of which 124 (55 %) were prevalent and 102 (45 %) were incident PNETs. Annual incidence rate was 0.79 PNETs/year (95 % confidence interval [CI] 0.73 to 0.87). Overall growth rate was 0.10 mm/year (95 %CI 0.02 to 0.19; P = 0.01); PNETs < 10 mm (n = 198) did not grow (P = 0.23), whereas PNETs >/= 10 mm (n = 28) grew 0.44 mm/year (95 %CI 0.10 to 0.78; P = 0.01). Prevalent PNETs grew 0.21 mm/year (95 %CI 0.10 - 0.32; P < 0.001), whereas incident PNETs did not grow (P = 0.26). Conclusions The annual growth rate of small, solid PNETs in patients with MEN1 is lower than previously thought. Surveillance intervals could probably be prolonged without compromising safety. CI - (c) Georg Thieme Verlag KG Stuttgart . New York. FAU - Kappelle, Wouter F W AU - Kappelle WF AD - Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands. FAU - Valk, Gerlof D AU - Valk GD AD - Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. FAU - Leenders, Max AU - Leenders M AD - Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands. FAU - Moons, Leon M G AU - Moons LM AD - Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands. FAU - Bogte, Auke AU - Bogte A AD - Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands. FAU - Siersema, Peter D AU - Siersema PD AD - Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands. FAU - Vleggaar, Frank P AU - Vleggaar FP AD - Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands. LA - eng PT - Journal Article DEP - 20161214 PL - Germany TA - Endoscopy JT - Endoscopy JID - 0215166 SB - IM CIN - Endoscopy. 2017 Jan;49(1):103. PMID: 28068723 MH - Adult MH - *Endosonography MH - Female MH - Humans MH - Male MH - Middle Aged MH - Multiple Endocrine Neoplasia Type 1/*diagnostic imaging MH - Neuroendocrine Tumors/*diagnostic imaging/pathology/surgery MH - Pancreatic Neoplasms/*diagnostic imaging/pathology/surgery MH - *Population Surveillance MH - Prospective Studies MH - *Tumor Burden EDAT- 2016/12/16 06:00 MHDA- 2017/08/31 06:00 CRDT- 2016/12/16 06:00 PHST- 2016/12/16 06:00 [pubmed] PHST- 2017/08/31 06:00 [medline] PHST- 2016/12/16 06:00 [entrez] AID - 10.1055/s-0042-119402 [doi] PST - ppublish SO - Endoscopy. 2017 Jan;49(1):27-34. doi: 10.1055/s-0042-119402. Epub 2016 Dec 14.